Paper33100710
Effectiveness and Cost-Effectiveness of Prophylactic Voriconazole and Fluconazole Regarding Prevention of Post-hematopoietic Stem Cell Transplantation Invasive Fungal Infection and Its Related Death: A Single Center Experience.
El-Ghammaz AMS and 7 others. Indian J Hematol Blood Transfus, 2020. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness and Cost-Effectiveness of Prophylactic Voriconazole and Fluconazole Regarding Prevention of Post-hematopoietic Stem Cell Transplantation Invasive Fungal Infection and Its Related Death: A Single Center Experience. Papers, record 33100710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33100710
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Effectiveness and Cost-Effectiveness of Prophylactic Voriconazole and Fluconazole Regarding Prevention of Post-hematopoietic Stem Cell Transplantation Invasive Fungal Infection and Its Related Death: A Single Center Experience.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25887385 | Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients. | BMC Infect Dis | 2015 | https://conductscience.org/library/papers/25887385 | PubMed |
| 2 | 1542320 | A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1542320 | PubMed |
| 3 | 20826719 | Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. | Blood | 2010 | https://conductscience.org/library/papers/20826719 | PubMed |
| 4 | 17287717 | Trends in the epidemiology of invasive fungal infections. | Nihon Ishinkin Gakkai Zasshi | 2007 | https://conductscience.org/library/papers/17287717 | PubMed |
| 5 | 7769290 | Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. | J Infect Dis | 1995 | https://conductscience.org/library/papers/7769290 | PubMed |
| 6 | 17251530 | Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17251530 | PubMed |
| 7 | 12005089 | Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. | Pediatr Infect Dis J | 2002 | https://conductscience.org/library/papers/12005089 | PubMed |
| 8 | 15994282 | Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. | Blood | 2005 | https://conductscience.org/library/papers/15994282 | PubMed |
| 9 | 21042306 | Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success. | Bone Marrow Transplant | 2011 | https://conductscience.org/library/papers/21042306 | PubMed |
| 10 | 24372659 | The role of primary antifungal prophylaxis in patients with haematological malignancies. | Clin Microbiol Infect | 2014 | https://conductscience.org/library/papers/24372659 | PubMed |
| 11 | 21082966 | Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. | Expert Rev Hematol | 2009 | https://conductscience.org/library/papers/21082966 | PubMed |
| 12 | 16944217 | Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants. | Support Care Cancer | 2007 | https://conductscience.org/library/papers/16944217 | PubMed |
| 13 | 21880032 | Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation. | Br J Haematol | 2011 | https://conductscience.org/library/papers/21880032 | PubMed |
| 14 | 24026863 | Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species. | Eur J Clin Microbiol Infect Dis | 2014 | https://conductscience.org/library/papers/24026863 | PubMed |
| 15 | 20035021 | Safety of triazole antifungal drugs in patients with cancer. | J Antimicrob Chemother | 2010 | https://conductscience.org/library/papers/20035021 | PubMed |
| 16 | 23943184 | Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. | Am J Health Syst Pharm | 2013 | https://conductscience.org/library/papers/23943184 | PubMed |
| 17 | 21657801 | Cost benefit and cost effectiveness of antifungal prophylaxis in immunocompromised patients treated for haematological malignancies: reviewing the available evidence. | Pharmacoeconomics | 2011 | https://conductscience.org/library/papers/21657801 | PubMed |
| 18 | 18781877 | Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. | Clin Infect Dis | 2008 | https://conductscience.org/library/papers/18781877 | PubMed |
| 19 | 27663309 | Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study. | J Hematol Oncol | 2016 | https://conductscience.org/library/papers/27663309 | PubMed |
| 20 | 12689933 | Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. | Blood | 2003 | https://conductscience.org/library/papers/12689933 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42842202 | Antifungal prophylaxis in patients with haematological malignancies receiving chemotherapy or haematopoietic stem cell transplantation: a systematic review and network meta-analysis. | Infection | 2026 | https://conductscience.org/library/papers/42842202 | PubMed |
| 37887786 | Septic Obturation of a Knee Endoprosthesis Caused by Aspergillus clavatus. | Pathogens | 2023 | https://conductscience.org/library/papers/37887786 | PubMed |
| 33538201 | Current and promising pharmacotherapeutic options for candidiasis. | Expert Opin Pharmacother | 2021 | https://conductscience.org/library/papers/33538201 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33100710
GET https://conductscience.org/api/papers/v1/33100710/references?page=2